English
Home > Products > 50910-55-9

China 50910-55-9 Factory

The corporate keeps to the procedure concept "scientific administration, premium quality and performance primacy, buyer supreme for 50910-55-9,CAS NO 50910-55-9,Bromhexine intermediate,Bromhexine advance intermediate,2-Amino-3,5-dibromobenzaldehyde, Welcome any inquiry to our firm. We're going to be glad to establish pleasant business interactions with you!
50910-55-9, With the growing of the company, now our items sold and served at more than 15 countries around the world,such as Europe,North America,Middle-east,South America,Southern Asia and so on. As we bear in our mind that innovation is essential to our growth, new product development is constantly.Besides, Our flexible and efficient operation strategies,High quality products and solutions and competitive prices are exactly what our customers are looking for. Also a considerable service brings us good credit reputation.

Related Products

Hot Products

  • 3,4-Difluoroaniline

    3,4-Difluoroaniline

    Product Name:3,4-Difluoroaniline
    Molecular Formula:C6H5F2N
    Molecular Weight:129.11
    CAS Registry Number:3863-11-4
  • Hydroxychloroquine

    Hydroxychloroquine

    Product Name:Hydroxychloroquine
    Molecular Formula:C18H26ClN3O
    Molecular Weight:335.88
    CAS Registry Number:118-42-3
  • 2,5-Difluorophenylacetic acid

    2,5-Difluorophenylacetic acid

    Product Name:2,5-Difluorophenylacetic acid
    Molecular Formula:C8H6F2O2
    Molecular Weight:172.13
    CAS Registry Number:85068-27-5
  • Ornidazole

    Ornidazole

    Product Name:Ornidazole
    Molecular Formula:C7H10ClN3O3
    Molecular Weight;219.63
    CAS Registry Number;16773-42-5
  • Z-LYS(Z)-OH

    Z-LYS(Z)-OH

    Product Name:Z-LYS(Z)-OH
    Molecular Formula:C22H26N2O6
    Molecular Weight:414.45
    CAS Registry Number:405-39-0
  • 4'-Benzyloxy-2-bromopropiophenone

    4'-Benzyloxy-2-bromopropiophenone

    Product Name:4'-Benzyloxy-2-bromopropiophenone
    Molecular Formula:C16H15BrO2
    Molecular Weight:319.19
    CAS Registry Number:35081-45-9
  • Related Blog
  • Reviews

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Related Search

CAS NO 50910-55-9

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept